vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and IDEX Corporation (IEX). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $398.4M, roughly 1.6× IDEX Corporation). IDEX Corporation runs the higher net margin — 30.1% vs 3.3%, a 26.8% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 16.7%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -29.4%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
HIMS vs IEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $398.4M |
| Net Profit | $20.6M | $120.0M |
| Gross Margin | 71.9% | 99.9% |
| Operating Margin | 1.5% | 43.3% |
| Net Margin | 3.3% | 30.1% |
| Revenue YoY | 28.4% | 16.7% |
| Net Profit YoY | -20.8% | 25.7% |
| EPS (diluted) | $0.08 | $1.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $398.4M | ||
| Q1 26 | — | $407.7M | ||
| Q4 25 | $617.8M | $899.1M | ||
| Q3 25 | $599.0M | $878.7M | ||
| Q2 25 | $544.8M | $865.4M | ||
| Q1 25 | $586.0M | $814.3M | ||
| Q4 24 | $481.1M | $862.9M | ||
| Q3 24 | $401.6M | $798.2M |
| Q2 26 | — | $120.0M | ||
| Q1 26 | — | $128.3M | ||
| Q4 25 | $20.6M | $128.3M | ||
| Q3 25 | $15.8M | $127.8M | ||
| Q2 25 | $42.5M | $131.6M | ||
| Q1 25 | $49.5M | $95.5M | ||
| Q4 24 | $26.0M | $123.2M | ||
| Q3 24 | $75.6M | $119.1M |
| Q2 26 | — | 99.9% | ||
| Q1 26 | — | 94.9% | ||
| Q4 25 | 71.9% | 43.1% | ||
| Q3 25 | 73.8% | 44.5% | ||
| Q2 25 | 76.4% | 45.3% | ||
| Q1 25 | 73.5% | 45.3% | ||
| Q4 24 | 76.8% | 42.5% | ||
| Q3 24 | 79.2% | 44.3% |
| Q2 26 | — | 43.3% | ||
| Q1 26 | — | 45.0% | ||
| Q4 25 | 1.5% | 20.4% | ||
| Q3 25 | 2.0% | 21.1% | ||
| Q2 25 | 4.9% | 21.7% | ||
| Q1 25 | 9.9% | 17.4% | ||
| Q4 24 | 3.9% | 19.2% | ||
| Q3 24 | 5.6% | 21.0% |
| Q2 26 | — | 30.1% | ||
| Q1 26 | — | 31.5% | ||
| Q4 25 | 3.3% | 14.3% | ||
| Q3 25 | 2.6% | 14.5% | ||
| Q2 25 | 7.8% | 15.2% | ||
| Q1 25 | 8.4% | 11.7% | ||
| Q4 24 | 5.4% | 14.3% | ||
| Q3 24 | 18.8% | 14.9% |
| Q2 26 | — | $1.61 | ||
| Q1 26 | — | $1.71 | ||
| Q4 25 | $0.08 | $1.71 | ||
| Q3 25 | $0.06 | $1.70 | ||
| Q2 25 | $0.17 | $1.74 | ||
| Q1 25 | $0.20 | $1.26 | ||
| Q4 24 | $0.10 | $1.61 | ||
| Q3 24 | $0.32 | $1.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $586.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $4.0B |
| Total Assets | $2.2B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $586.2M | ||
| Q1 26 | — | $580.0M | ||
| Q4 25 | $228.6M | $580.0M | ||
| Q3 25 | $345.8M | $593.8M | ||
| Q2 25 | $1.1B | $568.2M | ||
| Q1 25 | $273.7M | $594.1M | ||
| Q4 24 | $220.6M | $620.8M | ||
| Q3 24 | $165.5M | $633.2M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.1B |
| Q2 26 | — | $4.0B | ||
| Q1 26 | — | $4.0B | ||
| Q4 25 | $540.9M | $4.0B | ||
| Q3 25 | $581.0M | $4.0B | ||
| Q2 25 | $562.7M | $4.0B | ||
| Q1 25 | $549.3M | $3.9B | ||
| Q4 24 | $476.7M | $3.8B | ||
| Q3 24 | $440.1M | $3.8B |
| Q2 26 | — | $6.9B | ||
| Q1 26 | — | $6.9B | ||
| Q4 25 | $2.2B | $6.9B | ||
| Q3 25 | $2.2B | $7.0B | ||
| Q2 25 | $1.9B | $6.9B | ||
| Q1 25 | $891.7M | $6.8B | ||
| Q4 24 | $707.5M | $6.7B | ||
| Q3 24 | $602.3M | $7.0B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | — |
| Free Cash FlowOCF − Capex | $-2.5M | $86.0M |
| FCF MarginFCF / Revenue | -0.4% | 21.6% |
| Capex IntensityCapex / Revenue | 10.3% | 4.4% |
| Cash ConversionOCF / Net Profit | 2.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | $654.3M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $61.3M | $209.5M | ||
| Q3 25 | $148.7M | $203.5M | ||
| Q2 25 | $-19.1M | $161.7M | ||
| Q1 25 | $109.1M | $105.7M | ||
| Q4 24 | $86.4M | $172.6M | ||
| Q3 24 | $85.3M | $205.3M |
| Q2 26 | — | $86.0M | ||
| Q1 26 | — | $189.8M | ||
| Q4 25 | $-2.5M | $189.8M | ||
| Q3 25 | $79.3M | $188.7M | ||
| Q2 25 | $-69.5M | $146.9M | ||
| Q1 25 | $50.1M | $91.4M | ||
| Q4 24 | $59.5M | $157.1M | ||
| Q3 24 | $79.4M | $191.6M |
| Q2 26 | — | 21.6% | ||
| Q1 26 | — | 46.6% | ||
| Q4 25 | -0.4% | 21.1% | ||
| Q3 25 | 13.2% | 21.5% | ||
| Q2 25 | -12.8% | 17.0% | ||
| Q1 25 | 8.5% | 11.2% | ||
| Q4 24 | 12.4% | 18.2% | ||
| Q3 24 | 19.8% | 24.0% |
| Q2 26 | — | 4.4% | ||
| Q1 26 | — | 15.6% | ||
| Q4 25 | 10.3% | 2.2% | ||
| Q3 25 | 11.6% | 1.7% | ||
| Q2 25 | 9.3% | 1.7% | ||
| Q1 25 | 10.1% | 1.8% | ||
| Q4 24 | 5.6% | 1.8% | ||
| Q3 24 | 1.5% | 1.7% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 2.98× | 1.63× | ||
| Q3 25 | 9.43× | 1.59× | ||
| Q2 25 | -0.45× | 1.23× | ||
| Q1 25 | 2.20× | 1.11× | ||
| Q4 24 | 3.32× | 1.40× | ||
| Q3 24 | 1.13× | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
